Stratégies des laboratoires pharmaceutiques face au GAFAM

Abstract : Over the last two decades, digital technology has transformed, sometimes violently, many sectors, despite being considered as unshakeable: music and cinema, media and hospitality industries, catering trade...Protected so far, the pharmaceutical industry is watching helplessly, a horde of « digital barbarians » crossing its borders and causing profound changes in traditional medicine. The objective of this professional thesis is to look toward future and determine if pharmaceutical companies will be able to survive in this new digital environment. First, we will seek to understand the reasons leading some big companies to fail. Then, through a detailed analysis of the pharmaceutical industry, we will try to evaluate if such factors are threatening or not the pharmaceutical companies. Finally, this thesis also focuses on the strategies used by digital companies to disrupt an industry, with the aim of helping pharmaceutical firms to compete with these new entrants.
Document type :
Master Thesis
Complete list of metadatas

Cited literature [117 references]  Display  Hide  Download

https://dumas.ccsd.cnrs.fr/dumas-02100281
Contributor : Bu Carreire Université de Bordeaux <>
Submitted on : Monday, April 15, 2019 - 4:53:36 PM
Last modification on : Friday, June 28, 2019 - 1:29:08 AM

File

Pharmacie_2019_VANNI.pdf
Files produced by the author(s)

Identifiers

  • HAL Id : dumas-02100281, version 1

Collections

Citation

Jérôme Vanni. Stratégies des laboratoires pharmaceutiques face au GAFAM. Sciences pharmaceutiques. 2018. ⟨dumas-02100281⟩

Share

Metrics

Record views

27

Files downloads

34